Radiopharm Theranostics: A unique cancer treatment with solid early trial results
Listen to Radiopharm Theranostics Managing Director Riccardo Canevari talk to Matt Birney on the Bulls N’ Bears Report about Radiopharm’s UK trial for its cancer treatment that is designed to seek and destroy tumours.